fibrobiologics.com (FBLG): Bathi resik saben saham (EPS TTM)

Is it worth investing in FibroBiologics, Inc. (FBLG), which has developed a unique system for combating multiple sclerosis and disc degeneration? The rolling 12-month net income per share provides the answer, and its current level is -5.62. FibroBiologics, Inc. (FBLG) is patenting tissue regeneration methods, offering affordable stem cell alternatives for cancer therapy. However, financial stability is currently based exclusively on venture capital and equity offerings.

FBLG (FibroBiologics Corp) riwayat Bathi resik saben saham sajrone patang kuartal pungkasan saka 21.02.2024 nganti 15.11.2026

Rincian analitis perusahaan FibroBiologics, Inc. (FBLG)

- kuotasi saiki lan rata-rata prakiraan nilai:

Bagan rega FibroBiologics Inc.|FBLG - Target median analis

- data kapitalisasi bursa:

Kapitalisasi pasar FibroBiologics Inc.|FBLG - Nilai Wutuh Bisnis

- rincian valuasi buku bisnis:

Nilai Buku saben Saham FibroBiologics|FBLG - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku fibrobiologics.com|FBLG - Aset Agregat Perusahaan

- informasi babagan utang lan solvabilitas:

Utang marang Ekuitas FibroBiologics, Inc.|FBLG - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas FibroBiologics Corp|FBLG - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku FibroBiologics Corp|FBLG - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan FibroBiologics|Likuiditas cepet fibrobiologics.com

- indikator pendapatan resik lan kelipatan nilai:

FBLG - Penghasilan resik perusahaan|Bathi sing dikarepake FibroBiologics, Inc.|FBLG - Rasio rega marang bathi|Rega marang bathi mangsa ngarep FibroBiologics Corp|FBLG - Rega marang bathi kanthi panyesuaian wutah|Pangali EV/EBITDA FibroBiologics Corp|FBLG - Bathi operasional sadurunge potongan amortisasi|Bathi resik saben saham (EPS TTM) FibroBiologics|FBLG - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan fibrobiologics.com|FBLG - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep FibroBiologics, Inc.

- data total pendapatan lan volume dodolan:

FBLG - Pendapatan reged perusahaan|Volume dodolan mangsa ngarep perusahaan FibroBiologics|FBLG - Rasio kapitalisasi pasar marang pendapatan|Multiplikator Forward P/S FibroBiologics|FBLG - Wutah pendapatan taunan sajrone rolas wulan kepungkur

Analisis dhasar perusahaan:FibroBiologics Inc. (FBLG)

FibroBiologics, Inc. (FBLG) is developing a unique fibroblast-based tissue regeneration technology protected by an extensive patent portfolio. The monetization of these innovations directly impacts the calculation of net income distributable to all shareholders. This indicator measures the business's actual ability to generate equity income, stripped of one-time factors. Analyzing the trend of the rolling 12-month earnings per share allows for an assessment of the operating model's sustainability. The stability of this line confirms the company's fundamental strength.

Analisis pesaing FibroBiologics, Inc.

MESO - Bathi saben saham sajrone rolas wulan pungkasan|Bathi resik saben saham sajrone patang kuartal pungkasan Lineage Cell Therapeutics Inc LCTX|Surrozen Inc. (SRZN) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi resik saben saham sajrone 12 wulan pungkasan Cryo-Cell International Inc|Bathi saben saham sajrone rolas wulan pungkasan Longeveron Inc|biorestorative.com (BRTX) - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi resik saben saham (EPS TTM) CELZ